
-
2011
Company Description
INTICA Biomedical develops a combined product that consists of targeted therapy and companion diagnostics for triple negative breast cancer.
INTICA Biomedical, Inc. develops a combination product consisting of Targeted Therapy & Companion Diagnostic for Triple Negative Breast Cancer (TNBC). The novel drug target DEspR and its associated pathway represent true breakthrough discoveries. The NCI and the Susan G Komen Foundation are actively supporting the company's development program in TNBC.
-
Manufacturer:
Science and Engineering -
Formed:
2011 -
Founders:
Nelson Ruiz Opazo -
Company Website:
-
Company E-mail:
-
Company Address:
23 Blueberry LaneLexington, MAUnited States -
CEO:
- Nelson Ruiz Opazo
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits